T-Therapeutics
T-Therapeutics is a biotechnology company developing T-cell receptor therapeutics for oncology and inflammatory diseases.
The UK Home Office lists T-Therapeutics as a licensed sponsor (A-rated, Skilled Worker route). They can sponsor work visas. We read every advert and list only roles that don't rule out sponsorship. We're showing 1 of their current openings.
Sponsor licence details
Sourced from the UK Home Office register of licensed sponsors.
Sponsorship history
Certificates of Sponsorship T-Therapeutics assigned each year, from Home Office figures released under the Freedom of Information Act.
Skilled Worker and Global Business Mobility routes. One certificate is assigned for each sponsored hire, visa extension or change of employer, so a person can be counted more than once. “1–5” is withheld by the Home Office; the 2025 figures list only sponsors with 5 or more (“—”). Matched to this employer by its name on the sponsor register. Sources: FOI 2025/12841 (2021–24), FOI2026/03501 (2025). Contains public sector information licensed under the Open Government Licence v3.0.
Licence timeline Pro
Every change we've seen on the Home Office register for T-Therapeutics, and what its recent adverts say about sponsorship.
See this employer's full licence history: when it was licensed, rating and route changes, and when it last offered sponsorship in an advert.
Unlock with ProAbout T-Therapeutics
T-Therapeutics is a biotechnology research company that develops T-cell receptor (TCR) based therapeutics. Spun out from the University of Cambridge, the company utilises its proprietary OpTiMus platform, which features a fully humanised TCR mouse, to generate a diverse range of antigen-specific human TCRs.
The business integrates mouse genome engineering, biopharmaceutical drug development, single-cell genomics, machine learning, and structural biology. It operates in the biotechnology sector to create biologics and TCR therapies.
Open roles
1 live position matched to this sponsor licence.